. DOVZE || FABLES || de Fleuues ou || Fontaines, auec || la description pour la Peinture, || & les Epigrammes. || Par P. D. T. || A Paris, || Chez Iean Richer, ruë sainct Iean de Latran, à || l'enseigne de l'arbre Verdoiant. || 1585. || Auec Priuilege du Roy. Pet. in-12 de 23 f. chiffr. et 1 f. blanc, mar. bl., fil., dos orné, tr. dor. (Trautz-Bauzonnet.)

Fables (Douze) de Fleuves ou Fontaines (1585)

LA PAIX FAICTE A || CHAMBRAY en || tre lempereur || [et] le tres crestiẽ || Roy de france auec || leurs aliez. — [A la fin :] ¶ Imprime a paris pour philipot le cocq li- || brayre demourãt a chãbray en la rue taueau. S. d. [1508], in-4 goth. de 10 f., dont la page la plus pleine contient 36 lignes, sign. a par 6, b par 4, mar. v., fil., comp., dos orné, tr. dor. (Petit, successeur de Simier.)

Ladam (Nicaise). La Paix faicte a Chambray (1508)

¶ LE DOVBLE DES LETTRES || Que le || grant Turc Escript a mõsieur le grãt mai || stre de Rodes Enuiron la sainct Iehan/ lã mil || ccccc. xxij Auec vne. epistre de la Cite de Rodes || enuoyee A la Saincte foy Catolicque. — [A la fin :] ¶ Compose par songeur dit bethune, herault darmes || de lempereur Charles daustrice pour Anthoine mẽ || bre libraire qui fait le libraire. || Cum Preuilegio. In-4 goth. de 4 f. non chiffr. dont la page la plus pleine a 31 lignes, impr. en grosses lettres de forme, sans sign., mar. r. jans., tr. dor. (Trautz-Bauzonnet.)

Ladam (Nicaise). Epistre de la cité de Rodes (1522)

¶ COPIE DER BRIEVEN || VAN DEN GROOTẽ TURCK ghescreuẽ aẽ mijn Heere dẽ || grootẽ meestere van Rodes omtrẽt sint Ians misse || laetst ledẽ anno. M. ccccc. xxij. En oec eẽ Epistel vã || d' stadt vã Rodes / aẽ dat heylich Catholicke geloue. || Rodes. — [A la fin] : ¶ Dese Copie es vandẽ walsche ghetranslateert in || onsen tale Eñ is eerst gecõponeert par songneur/ dict || Bethune. herault darmes. ons ghenadichs heerẽ dẽ || Keysere Chaerles. || ¶ Gheprent Tantwerpẽ by mi Adriaen van || Bergen int gulden Missael. || ¶ Cum Priuilegio. In-4 goth. de 4 f. de 33 lignes à la page pleine, impr. en grosses lettres de forme, sign. A, mar. r. jans., tr. dor. (Trautz-Bauzonnet.)

Ladam (Nicaise). Epistel van de stadt van Rodes (1522)

¶ LE VOYAGE et || expedition de Charles le quint em- || pereur en Africque cõtre la || ville de Argiere. || ¶ La description de larmee & voyage de || Lempereur en Africque contre la || ville de Argiere / enuoyee a || mõsieur de Langest / tra- || duicte de latin en || françois. || ¶ Mil. D. xlii [1542] || ¶ On les vend a Paris en la rue sainct Ia- || ques a lenseigne des troys Brochetz / par Be- || noist de Gourmont. In-8 de 20 f. non chiffr. de 25 lignes à la page, sign. A-E par 4, mar. br., riches entrelacs et rinceaux en mosaïque de mar. vert, citron et rouge, doublé de mar. bleu, feuillages à petits fers, dos orné, gardes de moire bleue, tr. dor., dans un étui de mar. v. (Lortic.)

Charles Quint, roi d'Espagne et empereur d'Allemagne, d'abord archiduc d'Autriche. Le Voyage et Expedition de Charles le quint en Africque contre la ville de Argiere (1542)

CONFERENCE AVEC M. CLAUDE Ministre de Charenton, Sur la Matiere de l'Eglise. Par Messire Jacques Benigne Bossuet, Evesque de Meaux, Conseiller du Roy en ses Conseils, cy-devant Précepteur de Monseigneur le Dauphin, premier Aumosnier de Madame la Dauphine. A Paris, Chez Sebastien Mabre-Cramoisy, Imprimeur du Roy, ruë Saint Jacques, aux Cicognes. M.DC.LXXXII [1682]. Avec Privilege du Roy. In-12 de 22 f., 504 p. et 1 f. pour l'Extrait du Privilége, mar. r., fil., dos orné, tr. dor. (Anc. rel.)

Bossuet (Jacques-Bénigne). Conference avec M. Claude (1682)

Efetividade no diagnóstico da tuberculose em Foz do Iguaçu, tríplice fronteira Brasil, Paraguai e Argentina

Objetivou-se avaliar a efetividade dos serviços de saúde no diagnóstico da tuberculose em Foz do Iguaçu-PR. Realizou-se uma pesquisa avaliativa, com desenho epidemiológico transversal. Foram entrevistados 101 doentes de tuberculose em 2009, utilizando um instrumento baseado no Primary Care Assessment Tool . A análise ocorreu a partir de proporções e respectivos intervalos de confiança (95%) e mediana. O Pronto Atendimento (37%) e a Atenção Básica à Saúde (ABS) (36%) foram os locais mais buscados. O acesso à consulta no mesmo dia alcançou 70%, mas a suspeição da doença foi menor que 47%; a baciloscopia realizada em 50% dos doentes. Concluiu-se que apesar desses serviços atenderem rapidamente, isso não determinou alcance do diagnóstico, levando o doente a procurar os serviços especializados, mais efetivos na descoberta dos casos. A busca pela ABS gerou maior tempo e maior número de retornos para o diagnóstico da tuberculose na tríplice fronteira.

The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse.

Catecholamines and alpha(1)-adrenergic receptors (alpha(1)-ARs) cause cardiac hypertrophy in cultured myocytes and transgenic mice, but heart size is normal in single KOs of the main alpha(1)-AR subtypes, alpha(1A/C) and alpha(1B). Here we tested whether alpha(1)-ARs are required for developmental cardiac hypertrophy by generating alpha(1A/C) and alpha(1B) double KO (ABKO) mice, which had no cardiac alpha(1)-AR binding. In male ABKO mice, heart growth after weaning was 40% less than in WT, and the smaller heart was due to smaller myocytes. Body and other organ weights were unchanged, indicating a specific effect on the heart. Blood pressure in ABKO mice was the same as in WT, showing that the smaller heart was not due to decreased load. Contractile function was normal by echocardiography in awake mice, but the smaller heart and a slower heart rate reduced cardiac output. alpha(1)-AR stimulation did not activate extracellular signal-regulated kinase (Erk) and downstream kinases in ABKO myocytes, and basal Erk activity was lower in the intact ABKO heart. In female ABKO mice, heart size was normal, even after ovariectomy. Male ABKO mice had reduced exercise capacity and increased mortality with pressure overload. Thus, alpha(1)-ARs in male mice are required for the physiological hypertrophy of normal postnatal cardiac development and for an adaptive response to cardiac stress.

The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism.

The peroxisome proliferator-activated receptor alpha is a ligand-activated transcription factor that plays an important role in the regulation of lipid homeostasis. PPARalpha mediates the effects of fibrates, which are potent hypolipidemic drugs, on gene expression. To better understand the biological effects of fibrates and PPARalpha, we searched for genes regulated by PPARalpha using oligonucleotide microarray and subtractive hybridization. By comparing liver RNA from wild-type and PPARalpha null mice, it was found that PPARalpha decreases the mRNA expression of enzymes involved in the metabolism of amino acids. Further analysis by Northern blot revealed that PPARalpha influences the expression of several genes involved in trans- and deamination of amino acids, and urea synthesis. Direct activation of PPARalpha using the synthetic PPARalpha ligand WY14643 decreased mRNA levels of these genes, suggesting that PPARalpha is directly implicated in the regulation of their expression. Consistent with these data, plasma urea concentrations are modulated by PPARalpha in vivo. It is concluded that in addition to oxidation of fatty acids, PPARalpha also regulates metabolism of amino acids in liver, indicating that PPARalpha is a key controller of intermediary metabolism during fasting.

Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.

Site-directed mutagenesis and molecular dynamics simulations of the alpha 1B-adrenergic receptor (AR) were combined to explore the potential molecular changes correlated with the transition from R (inactive state) to R (active state). Using molecular dynamics analysis we compared the structural/dynamic features of constitutively active mutants with those of the wild type and of an inactive alpha 1B-AR to build a theoretical model which defines the essential features of R and R. The results of site-directed mutagenesis were in striking agreement with the predictions of the model supporting the following hypothesis. (i) The equilibrium between R and R depends on the equilibrium between the deprotonated and protonated forms, respectively, of D142 of the DRY motif. In fact, replacement of D142 with alanine confers high constitutive activity to the alpha 1B-AR. (ii) The shift of R143 of the DRY sequence out of a conserved 'polar pocket' formed by N63, D91, N344 and Y348 is a feature common to all the active structures, suggesting that the role of R143 is fundamental for mediating receptor activation. Disruption of these intramolecular interactions by replacing N63 with alanine constitutively activates the alpha 1B-AR. Our findings might provide interesting generalities about the activation process of G protein-coupled receptors.

Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities.

The aims of this study were to investigate the usefulness of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as postmortem markers of sepsis and to compare C-reactive protein and procalcitonin values in serum, vitreous humor, and cerebrospinal fluid in a series of sepsis cases and control subjects, in order to determine whether these measurements may be employed for the postmortem diagnosis of sepsis. Two study groups were formed, a sepsis group (eight subjects coming from the intensive care unit of two university hospitals, with a clinical diagnosis of sepsis in vivo) and control group (ten autopsy cases admitted to two university medicolegal centers, deceased from natural and unnatural causes, without elements to presume an underlying sepsis as the cause of death). Serum C-reactive protein and procalcitonin concentrations were significantly different between sepsis cases and control cases, whereas serum tumor necrosis factor alpha, interleukin-6, and interleukin-8 values were not significantly different between the two groups, suggesting that measurement of interleukin-6, interleukin-8, and tumor necrosis factor alpha is non-optimal for postmortem discrimination of cases with sepsis. In the sepsis group, vitreous procalcitonin was detectable in seven out of eight cases. In the control group, vitreous procalcitonin was clearly detectable only in one case, which also showed an increase of all markers in serum and for which the cause of death was myocardial infarction associated with multi-organic failure. According to the results of this study, the determination of vitreous procalcitonin may be an alternative to the serum procalcitonin for the postmortem diagnosis of sepsis.

Parameters for successful monthly extended dosing of darbepoetin-alpha in patients undergoing hemodialysis.

AIM: To document the feasibility and report the results of dosing darbepoetin-alpha at extended intervals up to once monthly (QM) in a large dialysis patient population. MATERIAL: 175 adult patients treated, at 23 Swiss hemodialysis centres, with stable doses of any erythropoiesis-stimulating agent who were switched by their physicians to darbepoetin-alpha treatment at prolonged dosing intervals (every 2 weeks [Q2W] or QM). METHOD: Multicentre, prospective, observational study. Patients' hemoglobin (Hb) levels and other data were recorded 1 month before conversion (baseline) to an extended darbepoetin-alpha dosing interval, at the time of conversion, and once monthly thereafter up to the evaluation point (maximum of 12 months or until loss to follow-up). RESULTS: Data for 161 evaluable patients from 23 sites were included in the final analysis. At 1 month prior to conversion, 73% of these patients were receiving darbepoetin-alpha weekly (QW) and 27% of the patients biweekly (Q2W). After a mean follow-up of 9.5 months, 34% received a monthly (QM) dosing regimen, 52% of the patients were receiving darbepoetin-alpha Q2W, and 14% QW. The mean (SD) Hb concentration at baseline was 12.3 +/- 1.2 g/dl, compared to 11.9 +/- 1.2 g/dl at the evaluation point. The corresponding mean weekly darbepoetin-alpha dose was 44.3 +/- 33.4 microg at baseline and 37.7 +/- 30.8 microg at the evaluation point. CONCLUSIONS: Conversion to extended darbepoetin-alpha dosing intervals of up to QM, with maintenance of initial Hb concentrations, was successful for the majority of stable dialysis patients.

Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.

Integrin receptors are the main mediators of cell adhesion to the extracellular matrix. They bind to their ligands by interacting with short amino acid sequences, such as the RGD sequence. Soluble, small RGD-based peptides have been used to block integrin-binding to ligands, thereby interfering with cell adhesion, migration and survival, while substrate-immobilized RGD sequences have been used to enhance cell binding to artificial surfaces. This approach has several important medical applications, e.g. in suppression of tumor angiogenesis or stimulation of bone formation around implants. However, the relatively weak affinity of short RGD-containing peptides often results in incomplete integrin inhibition or ineffective ligation. In this work, we designed and synthesized several new multivalent RGD-containing molecules and tested their ability to inhibit or to promote integrin-dependent cell adhesion when used in solution or immobilized on substrates, respectively. These molecules consist of an oligomeric structure formed by alpha-helical coiled coil peptides fused at their amino-terminal ends with an RGD-containing fragment. When immobilized on a substrate, these peptides specifically promoted integrin alphaVbeta3-dependent cell adhesion, but when used in solution, they blocked alphaVbeta3-dependent cell adhesion to the natural substrates fibronectin and vitronectin. One of the peptides was nearly 10-fold more efficient than fibronectin or vitronectin in promoting cell adhesion, and almost 100-fold more efficient than a linear RGD tripeptide in blocking adhesion. These results indicate that alpha-helical coiled coil peptides carrying an amino-terminal RGD motif can be used as soluble antagonists or surface-immobilized agonists to efficiently inhibit or promote integrin alphaVbeta3-mediated cell adhesion, respectively.